Tenderwize
Back to tender search

Open house pharmaceutical rebate agreements Ribociclib, ATC L01EF02

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jun 03, 2028 · 657 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Ribociclib, ATC L01EF02

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

The open-house model does not guarantee any purchase volume; actual revenue depends on usage by AOK Bayern members.

The agreement automatically terminates if a public rebate contract for the same active substance is concluded, which co...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jul 2028
  • Supply of the pharmaceutical product Ribociclib (ATC L01EF02) to AOK Bayern under non-exclusive rebate agreements.
  • Contracts are identical and non-negotiable, following an open-house model.
Show full summary

Open house non-exclusive pharmaceutical rebate agreement for Ribociclib (ATC L01EF02) by AOK Bayern. The contracting authority intends to conclude identical, non-negotiable rebate agreements with any interested pharmaceutical company that meets the eligibility criteria. The agreement is not subject to procurement law according to the buyer. Contracts can be concluded from 01.08.2026 to 31.07.2028, with ongoing entry possible until 03.06.2028. No estimated value is provided.

Risks

The open-house model does not guarantee any purchase volume; actual revenue depends on usage by AOK Bayern members.

The agreement automatically terminates if a public rebate contract for the same active substance is concluded, which co...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible to participate.

Administrative

  • Submission of a signed contract, signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and a signed declaration of reliability.
  • Documents must be submitted either in paper form (two original copies, hand-signed) or electronically with a qualified electronic signature via the communication area of the...

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house pharmaceutical rebate agreements Ribociclib, ATC L01EF02

Non-exclusive rebate agreements for the active substance Ribociclib, ATC code L01EF02, for the supply of pharmaceutical products to AOK Bayern. Contracts are identical and non-negotiable. Performance in Bavaria, Germany.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jul 2026 - Jul 2028

Category

Pharmaceutical products

Deadline

Deadline Jun 03, 2028

Procurement Details

Publication date
14 Jun 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
408105-2026

Documents (2)

Similar tenders